Product Attributes CAS # : 863288-34-0 Molecular Formula : C152H252N44O42 Sequence (AA) : YADAIFTQSYRKVLAQLSARKLLQDIMSR Molecular Weight : ~3367.9 g/mol PubChem CID : 56841945 Half-Life : ~30 minutes Synonyms : Mod GRF (1-29), Modified GRF 1-29, CJC-1295 without DAC, Sermorelin analog Type : Synthetic research peptide (GHRH analog) Research Focus : Growth Hormone & Anti-Aging, Recovery & Performance Scientific References A new long-acting analog of growth hormone-releasing hormone with prolonged half-life in patients with adult GH deficiency Human RCT | Observational Sustained-release GHRH analog increases GH and IGF-I in healthy adults Human RCT Effects of GHRH analog CJC-1295 on growth hormone and IGF-I levels Human RCT | Observational GHRH analogs and their potential role in stimulating endogenous GH secretion Animal | In vitro Structure-activity studies of GHRH analogs with extended biological half-life In vitro Growth hormone-releasing hormone and its analogs: clinical applications and mechanisms Observational | Animal | In vitro CJC-1295 research summary: mechanism, dosage, and effects Observational | Animal Pulsatile GH secretion induced by GHRH analog administration in healthy subjects Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
While those numbers are modest compared to GLP-1 agonists, the advantage of AOD-9604 is its targeted mechanism and favorable safety profile
CagriSema CagriSema is an investigational fixed-dose combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, co-administered once weekly and studied in Phase 3 trials for obesity and type 2 diabetes.
By proactively addressing these issues, Dr
